Actionable kinase fusions in sarcoma have not been comprehensively described with the exception of ALK fusions in inflammatory myofibroblastic tumors (IMT) and NTRK1–3 fusions in infantile fibrosarcoma33–35. Here, NTRK1 is linked to inflammatory myofibroblastic tumor.